Literature DB >> 16770780

CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia.

Jaap C Reijneveld1, Ieke B Ginjaar, Wendy S Frankhuizen, Nicolette C Notermans.   

Abstract

As caveolin-3 deficiencies may explain persistent hyper-CK-emia, we performed CAV3 gene mutation analysis and immunohistochemistry for caveolin-3 in 31 patients with idiopathic hyper-CK-emia. In 2 of 29 patients who donated blood, variants in the CAV3 gene were detected. Although immunohistochemical analysis strongly suggested that caveolin-3 was properly localized in the muscle tissue of the two affected patients, it may not function normally and could thus explain their persistent hyper-CK-emia. Our findings contribute to the clarification of unexplained persistent hyper-CK-emia, but further research is needed before CAV3 gene mutation analysis becomes part of the routine evaluation of these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770780     DOI: 10.1002/mus.20593

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview.

Authors:  Spyridon Klinis; Athanasios Symeonidis; Dimitrios Karanasios; Emmanouil K Symvoulakis
Journal:  Biomed Rep       Date:  2016-11-30

Review 2.  Caveolinopathies: from the biology of caveolin-3 to human diseases.

Authors:  Elisabetta Gazzerro; Federica Sotgia; Claudio Bruno; Michael P Lisanti; Carlo Minetti
Journal:  Eur J Hum Genet       Date:  2009-07-08       Impact factor: 4.246

3.  Idiopathic Benign Hyper-CK-Emia.

Authors:  Prashant Kaushik; Anuradha Gonuguntla
Journal:  Int J Biomed Sci       Date:  2009-03

4.  Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes.

Authors:  Giulia Ricci; Isabella Scionti; Greta Alì; Leda Volpi; Virna Zampa; Marina Fanin; Corrado Angelini; Luisa Politano; Rossella Tupler; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2012-01-14       Impact factor: 4.296

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.